World Library  


Add to Book Shelf
Flag as Inappropriate
Email this Book

Plos One : Concurrent Versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma, Volume 8

By Chuang, Eric, Y.

Click here to view

Book Id: WPLBN0003945834
Format Type: PDF eBook :
File Size:
Reproduction Date: 2015

Title: Plos One : Concurrent Versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma, Volume 8  
Author: Chuang, Eric, Y.
Volume: Volume 8
Language: English
Subject: Journals, Science, Medical Science
Collections: Periodicals: Journal and Magazine Collection
Historic
Publication Date:
Publisher: Plos

Citation

APA MLA Chicago

Chuang, E. Y. (n.d.). Plos One : Concurrent Versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma, Volume 8. Retrieved from http://www.worldlibrary.org/


Description
Description : Sorafenib (SOR) is the only systemic agent known to improve survival for hepatocellular carcinoma (HCC). However, SOR prolongs survival by less than 3 months and does not alter symptomatic progression. To improve outcomes, several phase III trials are currently examining SOR with radiation (RT) for HCC utilizing heterogeneous concurrent and sequential treatment regimens. Our study provides preclinical data characterizing the effects of concurrent versus sequential RT-SOR on HCC cells both in vitro and in vivo. Concurrent and sequential RT-SOR regimens were tested for efficacy among 4 HCC cell lines in vitro by assessment of clonogenic survival, apoptosis, cell cycle distribution, and c-H2AX foci formation. Results were confirmed in vivo by evaluating tumor growth delay and performing immunofluorescence staining in a hind-flank xenograft model. In vitro, concurrent RT-SOR produced radioprotection in 3 of 4 cell lines, whereas sequential RT-SOR produced decreased colony formation among all 4. Sequential RT-SOR increased apoptosis compared to RT alone, while concurrent RT-SOR did not. Sorafenib induced reassortment into less radiosensitive phases of the cell cycle through G1-S delay and cell cycle slowing. More double-strand breaks (DSBs) persisted 24 h post-irradiation for RT alone versus concurrent RT-SOR. In vivo, sequential RT-SOR produced the greatest tumor growth delay, while concurrent RT-SOR was similar to RT alone. More persistent DSBs were observed in xenografts treated with sequential RT-SOR or RT alone versus concurrent RT-SOR. Sequential RT-SOR additionally produced a greater reduction in xenograft tumor vascularity and mitotic index than either concurrent RT-SOR or RT alone. In conclusion, sequential RT-SOR demonstrates greater efficacy against HCC than concurrent RT-SOR both in vitro and in vivo. These results may have implications for clinical decision-making and prospective trial design.

 

Click To View

Additional Books


  • Plos One : Experimental Pathways Towards... (by )
  • Plos One : Micu2, a Paralog of Micu1, Re... (by )
  • Plos One : Human Metapneumovirus Glycopr... (by )
  • Plos One : Dimethylarginine Dimethylamin... (by )
  • Plos One : Mri-monitored Intra-shunt Loc... (by )
  • Plos One : Spatiotemporal Dynamics of Hi... (by )
  • Plos One : the Role of Master Regulators... (by )
  • Plos One : Norspermidine and Novel Pdii ... (by )
  • Plos One : Hiv-1 Tropism Testing in Subj... (by )
  • Plos One : Dose-dependent Induction of M... (by )
  • Plos One : Tnf-a May Mediate Inflammasom... (by )
  • Plos One : Evaluation of the Zucker Diab... (by )
Scroll Left
Scroll Right

 



Copyright © World Library Foundation. All rights reserved. eBooks from World Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.